| Nanoparticle-based targeted drug delivery R Singh, JW Lillard Jr Experimental and molecular pathology 86 (3), 215-223, 2009 | 3274 | 2009 |
| Challenges in liver cancer and possible treatment approaches D Anwanwan, SK Singh, S Singh, V Saikam, R Singh Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1873 (1), 188314, 2020 | 1000 | 2020 |
| Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents S Singh, SK Singh, I Chowdhury, R Singh The open microbiology journal 11, 53, 2017 | 654 | 2017 |
| Past, present, and future technologies for oral delivery of therapeutic proteins R Singh, S Singh, JW Lillard Journal of pharmaceutical sciences 97 (7), 2497-2523, 2008 | 235 | 2008 |
| Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and p27KIP1 pathway SK Singh, S Banerjee, EP Acosta, JW Lillard, R Singh Oncotarget 8 (10), 17216, 2017 | 208 | 2017 |
| Drug delivery approaches for breast cancer SK Singh, S Singh, JW Lillard Jr, R Singh International journal of nanomedicine, 6205-6218, 2017 | 201 | 2017 |
| Inflammation, immunity, and cancer R Singh, MK Mishra, H Aggarwal Mediators of inflammation 2017, 2017 | 184 | 2017 |
| CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells SK Singh, MK Mishra, IEA Eltoum, S Bae, JW Lillard, R Singh Scientific reports 8 (1), 1-12, 2018 | 162 | 2018 |
| Morphological characterization of very small embryonic‐like stem cells (VSELs) by ImageStream system analysis EK Zuba‐Surma, M Kucia, A Abdel‐Latif, B Dawn, B Hall, R Singh, ... Journal of cellular and molecular medicine 12 (1), 292-303, 2008 | 142 | 2008 |
| miR 488* inhibits androgen receptor expression in prostate carcinoma cells K Sikand, JE Slaibi, R Singh, SD Slane, GC Shukla International Journal of Cancer 129 (4), 810-819, 2011 | 141 | 2011 |
| CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication UP Singh, C Venkataraman, R Singh, JW Lillard Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2007 | 130 | 2007 |
| Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion S Singh, R Singh, PK Sharma, UP Singh, SN Rai, LWK Chung, ... Cancer letters 283 (1), 29-35, 2009 | 102 | 2009 |
| Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer SK Singh, JW Lillard Jr, R Singh Cancer letters 427, 49-62, 2018 | 96 | 2018 |
| Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer S Banerjee, SK Singh, I Chowdhury, JW Lillard Jr, R Singh Frontiers in bioscience (Elite edition) 9, 235, 2017 | 96 | 2017 |
| Nanoparticles for delivery of active agents JW Lillard, R Singh, S Singh US Patent 8,568,784, 2013 | 96 | 2013 |
| CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion C Johnson-Holiday, R Singh, E Johnson, S Singh, CR Stockard, ... International journal of oncology 38 (5), 1279-1285, 2011 | 96 | 2011 |
| Bacterial contamination of frequently touched objects in a tertiary care hospital of Pokhara, Nepal: how safe are our hands? DR Bhatta, D Hamal, R Shrestha, S Hosuru Subramanya, N Baral, ... Antimicrobial Resistance & Infection Control 7, 1-6, 2018 | 93 | 2018 |
| Mitigating climate change for sugarcane improvement: role of silicon in alleviating abiotic stresses KK Verma, P Singh, XP Song, MK Malviya, RK Singh, GL Chen, ... Sugar Tech 22, 741-749, 2020 | 88 | 2020 |
| CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation CP El‐Haibi, R Singh, PK Sharma, S Singh, JW Lillard Jr Cell proliferation 44 (4), 311-319, 2011 | 87 | 2011 |
| Chemokines: key players in cancer progression and metastasis R Singh, JW Lilladr Jr, S Singh Frontiers in bioscience (Scholar edition) 3, 1569, 2011 | 82 | 2011 |
James W. Lillard, Jr.Morehouse School of Medicine在 msm.edu 的电子邮件经过验证
